“…In a classical sense, the most well-known structural classes are the α-helix and β-sheets through the pioneering work of Lehrer, Ganz, Boman, Zasloff, Hancock, and others [ 8 , 9 , 10 , 25 , 26 , 27 ]. In contrast, AMPs synthesized through extraribosomal pathways (e.g., the cyclic lipopeptides, polymyxins) [ 28 , 29 ], were known for several decades prior to the discovery of ribosomally synthesized AMPs [ 13 , 30 , 31 , 32 ]. While AMPs like the polymyxins and daptomycin are widely used clinically, those made exclusively of some of the 20 (excluding selenocysteine) conventional amino acids (including engineered derivatives of these AMPs) are yet to be clinically available.…”